Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Cytokinetics (CYTK)

Cytokinetics (CYTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Cytokinetics: Q1 Earnings Snapshot

Cytokinetics: Q1 Earnings Snapshot

CYTK : 62.11 (-2.98%)
2 Incredible Growth Stocks to Buy Right Now

These two biotech stocks could be big winners in the years ahead.

CYTK : 62.11 (-2.98%)
VKTX : 74.65 (-6.92%)
Cytokinetics: Q4 Earnings Snapshot

Cytokinetics: Q4 Earnings Snapshot

CYTK : 62.11 (-2.98%)
Markets Today: Stocks Slip on Hawkish Fed Comments

Morning Markets March E-Mini S&P 500 futures (ESH24 ) are down -0.30%, and March Nasdaq 100 E-Mini futures (NQH24 ) are down -0.19%. Stock index futures this morning are mildly lower as higher bond yields...

ESM24 : 5,240.00 (+0.02%)
NQM24 : 18,233.25 (+0.10%)
BA : 178.63 (-1.45%)
APD : 250.70 (+0.04%)
ZS : 174.31 (+1.37%)
MAT : 18.70 (-0.90%)
CYTK : 62.11 (-2.98%)
GWW : 959.00 (+0.51%)
CAT : 355.15 (+0.96%)
EL : 132.33 (+0.51%)
FDMT : 25.69 (+0.20%)
CTLT : 55.82 (-0.29%)
2 Biotechs That Could Get Bought Out in 2024

These two biotechs have been frequent visitors to the buyout-rumor mill and for good reason.

CYTK : 62.11 (-2.98%)
BBIO : 28.22 (-1.78%)
Cytokinetics, New York Times rise; Iovance Biotherapeutics fall, Wednesday, 12/27/2023

Stocks that are trading heavily or have substantial price changes on Wednesday: Cytokinetics, New York Times rise; Iovance Biotherapeutics fall

CYTK : 62.11 (-2.98%)
NEM : 42.75 (-0.21%)
TMUS : 164.07 (-0.37%)
FCX : 51.80 (+1.41%)
TM : 218.42 (-3.88%)
CHRS : 1.88 (-11.32%)
NYT : 47.94 (-0.10%)
Cytokinetics: Q3 Earnings Snapshot

Cytokinetics: Q3 Earnings Snapshot

CYTK : 62.11 (-2.98%)
Cytokinetics: Q2 Earnings Snapshot

Cytokinetics: Q2 Earnings Snapshot

CYTK : 62.11 (-2.98%)
Cytokinetics (CYTK) Reports Q1 Loss, Tops Revenue Estimates

Cytokinetics (CYTK) delivered earnings and revenue surprises of -11.29% and 163.60%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

CYTK : 62.11 (-2.98%)
GERN : 3.80 (-2.06%)
Cytokinetics: Q1 Earnings Snapshot

Cytokinetics: Q1 Earnings Snapshot

CYTK : 62.11 (-2.98%)

Barchart Exclusives

Delta Air Lines: 3 Unusually Active Put Options to Generate Income
Delta Air Lines stock is having a good year, up 30% in 2024. The Barchart Technical Opinion rates it a Strong Buy, and analysts also rate it a Strong Buy. Not only is it an excellent stock to buy, but income investors might also want to consider selling one of Delta’s three unusually active put options from Thursday’s trading. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar